Company Filing History:
1 out of 1,289 
1 out of 13 Years Active: 2019
Title: Aditi Mehta: Innovator in Cancer Diagnosis and Therapy
Introduction
Aditi Mehta is a prominent inventor based in Bad Nauheim, Germany. She has made significant contributions to the field of cancer research, particularly in the diagnosis and therapy of lung cancer. Her innovative work has led to the development of a patented method that could potentially change the landscape of cancer treatment.
Latest Patents
Aditi Mehta holds a patent for "Isoforms of GATA6 and NKX2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapy." This invention relates to a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, specifically lung cancer. The method involves measuring the amounts of specific isoforms of GATA6 and/or NKX2-1 in a sample from the subject. Additionally, her invention includes a composition for use in medicine that comprises inhibitors of these specific isoforms. Furthermore, it encompasses a kit designed for assessing cancer susceptibility in individuals.
Career Highlights
Throughout her career, Aditi Mehta has worked with esteemed institutions such as the Max Planck Society for the Advancement of Science and Justus Liebig University Giessen. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Aditi has collaborated with notable colleagues, including Guillermo Barreto and Indrabahadur Singh. These partnerships have enriched her research and expanded the impact of her innovations in cancer therapy.
Conclusion
Aditi Mehta's contributions to cancer diagnosis and therapy through her innovative patent highlight her role as a leading inventor in the medical field. Her work not only advances scientific understanding but also holds promise for improving patient outcomes in cancer treatment.